Pinnacle West Capital Corporation
NYSE

REAL TIME PRICE

EXTENDED HOURS
Day’s Range -
52 Week Range -
Electric Services

B of A Securities Upgrades Pinnacle West Capital (PNW)

2024-03-19 07:19
US

Fintel reports that on March 18, 2024, B of A Securities upgraded their outlook for Pinnacle West Capital (NYSE:PNW) from Neutral to Buy.

Analyst Price Forecast Suggests 5.36% Upside

As of March 12, 2024, the average one-year price target for Pinnacle West Capital is 75.94. The forecasts range from a low of 68.68 to a high of $99.75. The average price target represents an increase of 5.36% from its latest reported closing price of 72.08.

See our leaderboard of companies with the largest price target upside.

The projected annual revenue for Pinnacle West Capital is 4,227MM, a decrease of 9.99%. The projected annual non-GAAP EPS is 4.64.

What is the Fund Sentiment?

There are 1144 funds or institutions reporting positions in Pinnacle West Capital. This is an increase of 27 owner(s) or 2.42% in the last quarter. Average portfolio weight of all funds dedicated to PNW is 0.19%, a decrease of 8.28%. Total shares owned by institutions increased in the last three months by 1.94% to 117,968K shares. PNW / Pinnacle West Capital Corporation Put/Call Ratios The put/call ratio of PNW is 1.34, indicating a bearish outlook.

What are Other Shareholders Doing?

PNW / Pinnacle West Capital Corporation Shares Held by Institutions

Capital Research Global Investors holds 6,508K shares representing 5.28% ownership of the company. In it's prior filing, the firm reported owning 3,002K shares, representing an increase of 53.88%. The firm increased its portfolio allocation in PNW by 88.87% over the last quarter.

Barrow Hanley Mewhinney & Strauss holds 5,721K shares representing 4.64% ownership of the company. In it's prior filing, the firm reported owning 5,701K shares, representing an increase of 0.34%. The firm decreased its portfolio allocation in PNW by 9.21% over the last quarter.

Invesco holds 4,016K shares representing 3.26% ownership of the company. In it's prior filing, the firm reported owning 3,992K shares, representing an increase of 0.62%. The firm decreased its portfolio allocation in PNW by 92.10% over the last quarter.

Lazard Asset Management holds 3,891K shares representing 3.16% ownership of the company. In it's prior filing, the firm reported owning 3,856K shares, representing an increase of 0.91%. The firm decreased its portfolio allocation in PNW by 67.79% over the last quarter.

VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 3,541K shares representing 2.87% ownership of the company. In it's prior filing, the firm reported owning 3,520K shares, representing an increase of 0.58%. The firm decreased its portfolio allocation in PNW by 12.36% over the last quarter.

Pinnacle West Capital Background Information
(This description is provided by the company.)

Pinnacle West Capital Corp., an energy holding company based in Phoenix, has consolidated assets of about $19 billion, about 6,300 megawatts of generating capacity and 6,200 employees in Arizona and New Mexico. Through its principal subsidiary, Arizona Public Service, the company provides retail electricity service to nearly 1.3 million Arizona homes and businesses.

Stories by George Maybach

BMO Capital Downgrades Expedia Group (EXPE)
Fintel reports that on May 3, 2024, BMO Capital downgraded their outlook for Expedia Group (NasdaqGS:EXPE) from Outperform to Market Perform.

B. Riley Securities Downgrades XPEL (XPEL)
Fintel reports that on May 3, 2024, B.

Piper Sandler Downgrades Expedia Group (EXPE)
Fintel reports that on May 3, 2024, Piper Sandler downgraded their outlook for Expedia Group (NasdaqGS:EXPE) from Overweight to Neutral.

William Blair Downgrades Wolfspeed (WOLF)
Fintel reports that on May 2, 2024, William Blair downgraded their outlook for Wolfspeed (NYSE:WOLF) from Outperform to Market Perform.

Baird Initiates Coverage of Spyre Therapeutics (SYRE) with Outperform Recommendation
Fintel reports that on May 2, 2024, Baird initiated coverage of Spyre Therapeutics (NasdaqGS:SYRE) with a Outperform recommendation.

EF Hutton Downgrades Mistras Group (MG)
Fintel reports that on May 2, 2024, EF Hutton downgraded their outlook for Mistras Group (NYSE:MG) from Buy to Hold.

JP Morgan Downgrades Metagenomi (MGX)
Fintel reports that on May 2, 2024, JP Morgan downgraded their outlook for Metagenomi (NasdaqGS:MGX) from Overweight to Neutral.

UBS Upgrades TJX Companies (TJX)
Fintel reports that on May 2, 2024, UBS upgraded their outlook for TJX Companies (NYSE:TJX) from Neutral to Buy.

UBS Upgrades Burlington Stores (BURL)
Fintel reports that on May 2, 2024, UBS upgraded their outlook for Burlington Stores (NYSE:BURL) from Sell to Neutral.

JP Morgan Upgrades Ziff Davis (ZD)
Fintel reports that on May 2, 2024, JP Morgan upgraded their outlook for Ziff Davis (NasdaqGS:ZD) from Neutral to Overweight.